Boston, MA · Founded 2014 · Privately Held (backing)
Operator of an ophthalmic biologics and device company intended for the treatment of presbyopia, hyperopia and myopia. Allotex is based in Boston, MA and was founded in 2014. It was valued at $358 million at its early-stage round in Mar 2018, the last priced event on record. It has raised $46.8 million across 1 recorded round; the latest was a $16.7 million early-stage round in Feb 2018.
PMV mark · valuation
$358.0M
Oct 2026
Priced at
its early-stage round
Mar 2018
Total raised
$46.8M
Last round
Early Stage VC
Feb 2018
Team — not yet on record
No current team members for Allotex are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Allotex with a free account
·Watch Allotex: the Monday email on marks, rounds and moves
